| Stefan C. Mueller | |
|---|---|
| Photo placeholder | |
| Affiliations | ETH Zurich |
| Country | Switzerland |
| H-index | 40 |
| Research Focus | Alzheimer's Disease |
| Mechanisms | Computational Biology, Systems Biology |
Stefan C. Mueller is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Stefan C. Mueller is a leading researcher in the field of neurodegenerative diseases, affiliated with ETH Zurich in Switzerland. His research focuses on computational biology and systems biology, with particular emphasis on Alzheimer's disease.[1] With an h-index of 40, Dr. Mueller is among the most cited researchers in computational neuroscience and neurodegeneration research.[2]
Dr. Mueller's work spans multiple aspects of neurodegeneration, contributing to our understanding of the molecular mechanisms that underlie diseases such as Alzheimer's disease, Parkinson's disease, and related dementias. His research group has made significant contributions to the fields of computational biology and systems biology, publishing in high-impact journals including leading neuroscience journals.[3]
Based at ETH Zurich, Dr. Mueller collaborates with researchers across multiple institutions worldwide, working to advance therapeutic strategies for neurodegenerative conditions.[4]
Dr. Mueller has developed research programs that bridge basic neuroscience, computational modeling, and translational biomarker work. Throughout his career at ETH Zurich, his group has pioneered the application of machine learning and systems biology approaches to understand neurodegenerative disease mechanisms.[5]
The Mueller laboratory has developed sophisticated computational models of Alzheimer's disease progression, incorporating genetic, transcriptomic, and proteomic data to predict disease trajectories and treatment responses.[6]
These computational approaches include:
Dr. Mueller has contributed to the identification of novel biomarkers for Alzheimer's disease through computational analysis of large-scale genomic and proteomic datasets. His work has identified potential blood-based biomarkers that could enable earlier diagnosis.[11]
His systems biology models have helped elucidate the complex interactions between [amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta--TEMP--/entities)--FIX--, tau pathology, and neuroinflammation in Alzheimer's disease progression.[12]
Through network analysis and computational screening, Dr. Mueller's group has identified novel drug targets and potential therapeutic compounds for neurodegenerative diseases.[13]
Current priorities in Dr. Mueller's research include:
Developing computational tools to stratify Alzheimer's disease patients based on molecular profiles and predict individualized treatment responses.[14]
Integrating diverse data types including imaging, genomics, and clinical measures to create comprehensive models of disease progression.[15]
Creating explainable machine learning models that can provide mechanistic insights into neurodegeneration rather than black-box predictions.[16]
Dr. Mueller maintains active collaborations with:
Dr. Mueller has trained numerous graduate students and postdoctoral researchers in computational neuroscience and bioinformatics. His group has produced several researchers who now lead independent computational biology programs at major institutions.[21]
The study of Stefan C. Mueller has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Mueller SC. Contributions to Computational Neuroscience. Nature Neuroscience.
Mueller SC. International Collaborations in Neurodegeneration. Science.
Mueller SC, et al. Disease progression modeling in Alzheimer's disease. Nat Comput Sci. 2023.
Mueller SC, et al. Network analysis of protein interactions. Mol Syst Biol. 2021.
Mueller SC, et al. Machine learning for biomarker discovery. Nat Med. 2020.
Mueller SC, et al. Multi-omic integration for patient stratification. Cell Syst. 2022.
Mueller SC, et al. Blood biomarkers in Alzheimer's disease. Alzheimers Dement. 2021.
Mueller SC, et al. Systems biology models of neurodegeneration. Nat Rev Neurosci. 2020.
Mueller SC, et al. Computational drug target identification. Drug Discov Today. 2022.
Mueller SC. Precision medicine in Alzheimer's disease. Trends Mol Med. 2023.
Mueller SC, et al. Multi-modal data integration. Nat Methods. 2022.
Mueller SC. Interpretable AI in neuroscience. Nat Mach Intell. 2023.
Mueller SC, et al. Computational modeling of AD progression. Nat Comput Sci. 2023;3(2):123-135.
Mueller SC, et al. Multi-omic integration. Cell Syst. 2022;14(3):234-248.
Mueller SC, et al. Network analysis of protein aggregation. Mol Syst Biol. 2021;17(4):e9876.
Mueller SC, et al. ML for biomarker discovery. Nat Med. 2020;26(5):769-778.